ACE inhibitor
ACE inhibitor is a pharmaceutical drug with 10 clinical trials. Currently 3 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 2 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
6
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
2 of 2 finished
0.0%
0 ended early
3
trials recruiting
10
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Short-Term Effects of Antihypertensive Drugs on Postural Balance and Fall Risk
A RAndomizeD Intervention for Cardiovascular and Lifestyle Risk Factors in Prostate Cancer Patients
Efficacy of Dapagliflozin in Early Diabetic Nephropathy in Type 1 Diabetes
Replication of the PARADIGM-HF Heart Failure Trial in Healthcare Claims Data.
The Use of Angiotensin Converting Enzyme Inhibitors and Incident Respiratory Infections, Are They Harmful or Protective?
Clinical Trials (10)
Short-Term Effects of Antihypertensive Drugs on Postural Balance and Fall Risk
A RAndomizeD Intervention for Cardiovascular and Lifestyle Risk Factors in Prostate Cancer Patients
Efficacy of Dapagliflozin in Early Diabetic Nephropathy in Type 1 Diabetes
Replication of the PARADIGM-HF Heart Failure Trial in Healthcare Claims Data.
The Use of Angiotensin Converting Enzyme Inhibitors and Incident Respiratory Infections, Are They Harmful or Protective?
Coronavirus (COVID-19) ACEi/ARB Investigation
Effect of Sodium Glucose co Transporter 2 Inhibitor ( SGLT2) on Proteinuria in Diabetic Patients
Endothelial Function Evaluation in Patients With PAOD Treated With Sulodexide + Conventional Treatment (CT) Vs CT Alone
Adolescent Type 1 Diabetes Cardio-Renal Intervention Trial
Efficacy and Safety of a Combination of Mycophenolate Mofetil and Corticosteroid in Advanced IgA Nephropathy
All 10 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 10